Drug Database
Back to search

Poland· PL-100098585

Seractil

A dexibuprofen product containing dexibuprofenum, registered in Poland by Biofarm Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC M01AE14

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSeractilATCM01AE14REGISTER NO.PL-100098585PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dexibuprofenumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dexibuprofen is registered in 10 of 19 countries.

Countries holding a registration under ATC M01AE14 (dexibuprofen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose
Search dexibuprofen products by name

Dexibuprofen · ATC M01AE14

10 / 19 countries

  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Italyprice
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dexibuprofen costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), the median price runs from $0.55 in Italy to $1.51 in Switzerland — a ×2.7 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Dexibuprofen · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$1.51
  • IT Italy$0.55
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Dexibuprofenum
Manufacturer
Biofarm Sp. z o.o.
Country
Poland (PL)
ATC code
M01AE14
ATC class
Dexibuprofen
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909990844333
  • gtin
    05909990844319
  • gtin
    05909990844326

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for dexibuprofen.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dexibuprofen against other medicinesHow interaction checks work

Dexibuprofen · interactions on record

82 records

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Dexibuprofen in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dexibuprofen products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Atriscal, Dexibuprofen Fairmed
  • Czechia · Dexibuprofen Strides, Ibolex
  • Germany · Deltaran, Dexibu
  • Denmark · Seractiv
  • Spain · Atriscal, Dexibuprofeno Strides
  • United Kingdom (Northern Ireland) · Dexibuprofen Strides Pharma Uk
  • Greece · Seractil
  • Hungary · Dexibuprofen Gebro, Dexibuprofen Strides
  • Italy · Fenextra, Seractil
  • Portugal · Seractil
  • Romania · Seractil
  • Sweden · Dexibuprofen Strides, Tradil
  • Slovakia · Dexibuprofén Strides, Ibolex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1284539e-99b8-42bc-9bca-903af991d975
GET /v1/drugs/1284539e-99b8-42bc-9bca-903af991d975?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909990844333 ¦ Rp ¦ 9887\n10 tabl.\n05909990844319 ¦ Rp ¦ 16840\n30 tabl.\n05909990844326 ¦ Rp ¦ 16841\n60 tabl.",
  "substance": "Dexibuprofenum 400 mg",
  "common_name": "Dexibuprofenum",
  "pl_product_id": "100098585",
  "pozwolenie_nr": "08443",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about dexibuprofen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console